Aug 05, 2024 / 08:00AM GMT
Masataka Kaji Kaji - Ajinomoto Co Inc - General Manager, IR Office
(Interpreted)
Good afternoon, everyone. Once again, this is Koji from the IR office of Ajinomoto. Now without further ado, we would like to explain the first quarter results for fiscal 2023. If you can open page 6, this is a summary of the first quarter.
For the first quarter, we achieved an increase in both revenue and profit. Revenue business profit we achieved the record profit and sales for the first quarter and for business profit, if we exclude the impact of Forge acquisition, its business profit increased by 7% compared to the same period of 2023. In the Seasonings and foods segment, Sauce and Seasonings overseas remain very solid.
In Frozen Foods segment, we have continued brand investment in accordance with the plan from the start of the year. So this led to achieving growth in main products.
In Healthcare and Other segment, revenue increased and profit increased significantly. Functional Materials, in particular, recorded a significant increase in both revenue and profit. Bio-Pharma Services,
Q1 2025 Ajinomoto Co Inc Earnings Call Transcript
Aug 05, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers